Skip to main content

#151156

Anti-Rb1 [Rb1 (1F8)]

Cat. #151156

Anti-Rb1 [Rb1 (1F8)]

Cat. #: 151156

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 3-4 weeks

Target: Retinoblastoma (Rb1)

Class: Monoclonal

Application: IHC ; IF ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: David Lane

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Rb1 [Rb1 (1F8)]
  • Alternate name: CD4 Molecule; T-Cell Surface Antigen T4/Leu-3; T-Cell Surface Glycoprotein CD4; CD4 Receptor; CD4 Antigen
  • Cancer: Breast cancer;Eye cancer
  • Cancers detailed: Breast cancer;Broadly Applicable;Retinoblastoma
  • Research fields: Cancer;Cell biology
  • Clone: Rb1 (1F8)
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 105 kDa
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Disease: Breast Cancer
  • Application: IHC ; IF ; IP
  • Description: The Retinoblastoma protein (Rb) is a transcription factor that controls cell cycle progression (at the G1/S phase transition) through its repression of E2F-mediated transcription. Mutation of the Rb gene is found frequently in human sarcomas, lung, bladder and breast carcinomas and is the molecular basis for hereditary disposition to retinoblastoma.
  • Immunogen: Rb-b-galactosidase fusion protein spanning nucleotides 1126-1973 and representing 283 mino acids of Human Rb cDNA
  • Isotype: IgG1
  • Myeloma used: Sp2/0-Ag14

Target Details

  • Target: Retinoblastoma (Rb1)
  • Molecular weight: 105 kDa
  • Target background: The Retinoblastoma protein (Rb) is a transcription factor that controls cell cycle progression (at the G1/S phase transition) through its repression of E2F-mediated transcription. Mutation of the Rb gene is found frequently in human sarcomas, lung, bladder and breast carcinomas and is the molecular basis for hereditary disposition to retinoblastoma.

Applications

  • Application: IHC ; IF ; IP

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

References

  • Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates.
  • Ragazzon et al. 2014. Eur J Endocrinol. 2014 Feb 4
  • 170(3):385-91. PMID: 24347427
  • Bandyopadhyay et al. 2007. Aging Cell. 6(4):577-91. PMID: 17578512.
  • Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi.
  • Lee et al. 2007. Clin Cancer Res. 13(3):832-8. PMID: 17289874.
  • Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer.
  • Bartkova et al. 2003. J Pathol. 200(2):149-56. PMID: 12754735.
  • Deregulation of the RB pathway in human testicular germ cell tumours.
  • Brtek et al. 1992. Oncogene. 7(1):101-8. PMID: 1741157.
  • Cellular localization and T antigen binding of the retinoblastoma protein.
  • Grand et al. 1989. Oncogene. 4(11):1291-8. PMID: 2682458.
  • The expression of the retinoblastoma gene product Rb1 in primary and adenovirus-transformed human cells.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.